La cadena de opciones muestra datos clave de las opciones de acciones de Focus Universal a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Focus Universal..

Focus Universal (NASDAQ:FCUV) Bolsa, Cadena de Opciones

Focus Universal

Focus Universal Inc develops and manufactures universal smart devices. Its product portfolio includes Universal Smart Instrumentation Platform, Ubiquitor, Universal Smart Controller, and Sensors. The company also supplies various air filtration systems. The Company consists of three types of operations- Focus and Focus Shenzhen (Corporate), Perfecular and Lusher (IoT Products), and AVX (IoT Installation Services). The majority of revenue is generated from IoT Installation Services. IoT Installation Services segment is an IoT installation and management company specializing in high-performance and easy-to-use audio/video, home theater, lighting control, automation, and integration.

Focus Universal Inc

ArcelorMittal is today providing an update on its decarbonization plans in Europe.
The Company has previously announced the intention to invest in lower carbon emissions "hydrogen ready" DRI-EAF facilities to replace several blast furnaces across our European business, as a key strategic first step towards reducing emissions. In all cases, the host countries offered funding support for these projects, with the approval of the European Commission.
These projects were premised on a favourable combination of policy, technology and market developments that would facilitate decarbonization investment by helping offset the significantly higher capital and operating costs that this transition strategy would involve. This included being able to use natural gas until green hydrogen became competitive.
However European policy, energy and market environments have not moved in a favourable direction. Green hydrogen is evolving very slowly towards being a viable fuel source and natural gas based DRI production in Europe is not yet competitive as an interim solution. Furthermore, there are significant weaknesses in the carbon border adjustment mechanism (CBAM), trade protection measures need strengthening in response to increasing imports due to overcapacity in China, and there is limited willingness among customers to pay premiums for low-carbon emissions steel.
Before taking final investment decisions it is necessary to have full visibility on the policy environment that will ensure higher cost steelmaking can be competitive in Europe without a global carbon price. &nbsp;&nbsp; We expect several important developments in 2025, including the scheduled review of the CBAM, an anticipated review of the steel safeguards, and the publication of the Steel and Metals Action Plan. When complete, these initiatives will provide the parameters needed to shape the business case for decarbonization investments in Europe.
In the meantime, we are continuing with engineering work, as well as analysing a phased approach that would first start with constructing electric arc furnaces, which can also be fed with scrap steel to significantly reduce emissions. &nbsp;&nbsp; ArcelorMittal remains committed to decarbonizing and achieving net-zero by 2050. Activity undertaken in Europe to date includes:
<ul>
<li>In May we commenced construction on a 1.1 million tonne capacity EAF at our long products plant in Gijón, Spain. This will ultimately lead to a reduction of 1 million tonnes of CO2e a year.</li>
<li>Good progress is being made with our efforts to increase production to 1.6 million tonnes a year by 2026 at our flat products plant in Sestao, Spain, where we have two EAFs. Once complete, much of this production will be our XCarb&#xAE; recycled and renewably produced low-carbon emissions steel.</li>
<li>We continue to lead the market with sales of our XCarb&#xAE; low-carbon emissions steel, which have a carbon footprint of as low as 300kg per tonne of steel produced, and are on track to double sales to c. 400,000 tonnes this year. &nbsp;</li>
</ul>
The longer timeline required for final investment decisions will not impact the Company's ability to meet customer demand for low-carbon emissions steel as the Sestao revamp project will materially increase the Company's ability to produce low-carbon emissions flat products.
Any revision to the current 2030 intensity targets will be set out in the forthcoming Climate Action Report 3. From an absolute emissions perspective, the absolute emissions of the Company's operations in Europe have reduced by 28.2% since 2018, largely due to lower production due to weak demand. &nbsp;&nbsp; Longer term, the Company remains committed to all technologies that offer the potential to take steelmaking to near-zero. This includes carbon capture utilisation and storage (CCUS), although like green hydrogen, this technology is likely to only make a meaningful difference after 2030. It already has one industrial scale CCU facility operational at its plant in Gent, Belgium, and a further two pilot projects underway in Gent.
Aditya Mittal, Chief Executive, ArcelorMittal, commented:
"ArcelorMittal remains absolutely committed to decarbonization. It is the right thing to do, both for the company and the planet. I remain confident that we can still achieve our net-zero by 2050 target, but the shape of how we will achieve this could differ from what was previously announced.
"We have been very grateful for the support offered to date by different governments to help accelerate this process. But the scale of the challenge requires further policy initiatives to unlock increased investment. We would have liked to move faster, but the reality is the regulatory environment required to support the business case for investments is not yet in place.
"I hope to see new policies coming into play that will support an accelerated transition. The Green Deal Industrial Plan and the Steel and Metals Action Plan, and the legislation flowing from them, will be important, as well as regulation to stimulate the demand signal. While we do have customers that want low-carbon steel, those that do and are willing to pay a premium are still very much in the minority. &nbsp;&nbsp; "I expect policy decisions taken in 2025 will help bring clarity on how we will move forward to decarbonize our assets, taking advantage of our unique global profile, superior technology and raw materials mix and industry leading innovation."
&nbsp;

News

ArcelorMittal Signals Shift in European Decarbonization Strategy Amid Policy Delays

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Monday.
U.S. stocks settled higher on Friday, with the Dow Jones index and S&amp;P 500 hitting fresh records during the session. Major indices on Wall Street recorded gains last week, with the Dow gaining around 2% and the S&amp;P 500 adding around 1.7%.
Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) shares jumped around 16.5% on Monday after the company reported better-than-expected third-quarter results and raised its 2024 outlook.
On the economic data front, the Chicago Fed National Activity Index fell to -0.40 in October compared to -0.27 in the previous month and versus market estimates of -0.20. The Dallas Fed's Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, materials, and consumer discretionary stocks recording the biggest gains on Monday. However, energy and information technology stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 440 points to 44,736.57 on Monday. The S&amp;P 500 rose 0.30% to 5,987.37, while the Nasdaq Composite rose 0.27% to close at 19,054.84 during Monday's session.
Investors are awaiting earnings results from Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>), HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>), and Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 61.5, the index remained in the &#8220;Greed&#8221; zone on Monday, versus a prior reading of 60.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Markets

Trading Ideas

BBWI

DELL

Dow, S&P 500 Reach Fresh Highs: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

NTRA

Reported Earlier, Natera To Present Latest Data On Signatera At 2024 San Antonio Breast Cancer Symposium

Elon Musk&#8216;s company, Neuralink, is set to initiate a new feasibility trial involving its innovative brain implant technology and a robotic arm. This trial aims to explore the safety and effectiveness of Neuralink&#8217;s wireless brain-computer interface and surgical robot.
What Happened: The study, named PRIME, will focus on patients with quadriplegia, enabling them to control external devices through thought, Reuters reported on Tuesday. Neuralink plans to enroll participants from its ongoing PRIME trial into this feasibility study, as mentioned in a post on social media platform X.
Recently, Neuralink received <a href="https://www.benzinga.com/24/11/42103314/elon-musks-neuralink-gets-green-light-to-launch-brain-chip-trial-in-canada-recruitment-is-now-open">approval from Health Canada</a> to conduct a trial of its device in Canada. Canadian neurosurgeons, in collaboration with Neuralink, have been authorized to recruit six patients with paralysis for the study. In the U.S., Neuralink has already implanted the device in two patients, allowing one to engage in activities such as playing video games and browsing the internet.
See Also: <a href="https://www.benzinga.com/news/24/11/42157649/trumps-doge-co-lead-elon-musk-slams-lockheed-martins-f-35-fighter-jets-advocates-drone-warfare-as-pentagon-defends-1-8-trillion-program?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s DOGE Co-Lead Elon Musk Slams Lockheed Martin&#8217;s F-35 Fighter Jets, Advocates Drone Warfare As Pentagon Defends $1.8 Trillion Program</a>
The company reports that the device is functioning well in the second patient, who is&nbsp;using it to play video&nbsp;games and learn 3D design. The U.S. FDA and Neuralink have not yet provided further&nbsp;details on the feasibility study.
Why It Matters: The potential of Neuralink&#8217;s brain chip technology to transform lives has been a topic of interest since Musk first introduced the concept. As reported in July, Musk <a href="https://www.benzinga.com/startups/24/07/40016299/we-want-to-give-people-super-powers-elon-musk-envisions-neuralink-brain-chip-transforming-lives-like">envisioned the brain chip </a>offering superhuman abilities, akin to characters from science fiction like Geordi La Forge from Star Trek. The company, founded in 2016, aims to revolutionize the way humans interact with technology and address neurological disorders through brain-computer interfaces (BCIs). 
The initial human trials began earlier this year with Noland Arbaugh, a 30-year-old quadriplegic, who received the N1 Implant, allowing him to control a computer cursor with his thoughts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/42152721/tesla-cybertruck-part-of-donald-trumps-motorcade-will-vehicle-land-government-deals?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Cybertruck Part Of Donald Trump&#8217;s Motorcade, Will Vehicle Land Government Deals?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

General

Elon Musk's Neuralink To Launch New Feasibility Trial With Brain Implant And Robotic Arm

With U.S. stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) to report quarterly earnings at $1.29 per share on revenue of $9.63 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Best Buy shares rose 0.4% to $93.37 in after-hours trading.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>) agreed to be acquired by Roche in a $1.5 billion deal. Poseida Therapeutics shares jumped 11.2% to $3.18 in the after-hours trading session.</li>
<li>Analysts expect HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) to post quarterly earnings at 93 cents per share on revenue of $13.99 billion. The company will release earnings after the markets close. HP shares fell 0.3% to $39.19 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) posted better-than-expected results for its third quarter and raised its guidance for the full year. Zoom reported third-quarter revenue of $1.18 billion, beating the consensus estimate of $1.16 billion. The communications company reported third-quarter adjusted earnings of $1.38 per share, beating analyst estimates of $1.31 per share. Zoom shares fell 5.6% to $84.09 in the after-hours trading session.</li>
<li>Analysts expect Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) to report quarterly earnings at $2.05 per share on revenue of $24.65 billion after the closing bell. Dell shares fell 0.8% to $143.00 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>
Photo courtesy: Flickr

PSTX

Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday

<ul>
<li>The annual dividend on the common stock of the Corporation was raised to $1.16 per share from $1.13 per share.</li>
<li>The Board of Directors authorized the first quarterly dividend of 29.00 cents ($0.2900) a share to be paid on February 18, 2025, to stockholders of record at the close of business on January 13, 2025.</li>
</ul>

Dividends

Reported Earlier, Hormel Foods Increases Annual Dividend By 3% To $1.16/Share; Declared First Quarterly Dividend Of $0.29/Share Payable February 18, 2025

CHARU

Reported Earlier, Charlton Aria Acquisition Announces Separate Trading Of Class A Shares And Rights Starting November 26

Berry plans to use proceeds from the transaction to pay down outstanding debt at Berry. Adjusted for both the cash distribution received in November 2024 on close of Berry's Health, Hygiene and Specialties Global Nonwovens and Films business ("HHNF") spin-off, and the net cash proceeds1 expected on the sale of Tapes, totaling $1.3 billion, Berry's pro forma net debt as of September 30, 2024 was approximately $5.9 billion (3.5x LTM net leverage).

BERY

Reported Earlier, Berry Global Sells Specialty Tapes Business To Nautic Partners For $540M

Justin Sun, the founder of the TRON (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/trx/usd">TRX</a>) blockchain, announced a $30 million investment in President-elect Donald Trump-backed cryptocurrency project&nbsp;World Liberty Financial&nbsp;(WLFI), lending support to the &#8220;Make America Great Again&#8221; movement.
What Happened: On Monday, Sun revealed on X that Tron became the largest investor in&nbsp;the decentralized finance (DeFi) project with the strategic expenditure. 
He said, &#8220;The U.S. is becoming the blockchain hub, and Bitcoin owes it to Donald Trump!  TRON is committed to making America great again and leading innovation. Let&#8217;s go!&#8221;
In response, the WLFI team said they were honored to have the support of Sun and the Tron ecosystem.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are thrilled to invest $30 million in World Liberty Financial <a href="https://twitter.com/worldlibertyfi?ref_src=twsrc%5Etfw">@worldlibertyfi</a> as its largest investor. The U.S. is becoming the blockchain hub, and Bitcoin owes it to <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a>! TRON is committed to making America great again and leading innovation. Let&#39;s go! <a href="https://t.co/cISTsVYP1f">pic.twitter.com/cISTsVYP1f</a>
&mdash; H.E. Justin Sun &#x1f34c; (@justinsuntron) <a href="https://twitter.com/justinsuntron/status/1861121947372773545?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Sun&#8217;s $30 million investment catapulted total sales of the project&#8217;s governance token past $50 million, <a href="https://dune.com/fergmolina/world-liberty-financial" target="_blank" rel="noreferrer noopener">according&nbsp;</a>to a Dune Analytics dashboard, although still a long way away from the ambitious $300 million target.
The project had a slow start, managing to raise just 4% of its token presale target within the first 48 hours of its launch.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42180180/peter-schiff-warns-trumps-bitcoin-support-could-lead-to-economic-chaos-make-america-weaker-as-wall-street-misallocates-bigly">Peter Schiff Warns Trump&#8217;s Bitcoin Support Could Lead To Economic Chaos, Make America &#8216;Weaker&#8217; As Wall Street Misallocates &#8216;Bigly&#8217;</a>
Why It Matters: Promoted aggressively by Trump and his family,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40905315/donald-trumps-new-crypto-project-world-liberty-financial-everything-you-need-to-know" target="_blank" rel="noreferrer noopener">the project</a>&nbsp;attracted significant attention right in the middle of the GOP nominee&#8217;s presidential campaign.
The WLFI token would serve as the platform&#8217;s governance token, enabling users to engage in borrowing, lending, and other DeFi activities. However, its non-transferable, non-yielding nature may have turned off speculative traders, adding to the lackluster presale.
According to the World Liberty Gold&nbsp;Paper, WLFI <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41395007/trump-affiliated-entity-will-get-75-of-world-liberty-financials-revenue-and-22-of-wlfi-tok">would allocate 75% of its protocol revenues</a> to a firm associated with the former President, DT Marks DEFI, LLC.
As for Sun, he remains one of the largest publicly known cryptocurrency investors, boasting a portfolio worth more than $1.8 billion, <a href="https://platform.arkhamintelligence.com/explorer/entity/justin-sun" target="_blank" rel="noreferrer noopener">data </a>from Arkham Intelligence revealed.
Photo Courtesy: Wikimedia Commons
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42179537/rumble-bets-on-bitcoin-with-new-treasury-strategy-ceo-calls-it-an-excellent-addition">Rumble Bets On Bitcoin With New Treasury Strategy, CEO Calls It An &#8216;Excellent Addition&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$TRX

Crypto Billionaire Justin Sun Pledges $30M Investment In Trump-Backed World Liberty Financial: What's Happening?

Sell-side clients benefit from simplified integration and connectivity to LTX, reduced operational risk and implementation costs and improved time-to-marke

Broadridge's LTX Partners With TransFICC, Offering  Faster Access And Lower Costs For Fixed Income eTrading

The Company expects to receive aggregate gross proceeds of US$8.20 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters an option, exercisable within forty-five (45) days after the closing of the Offering, to purchase up to an additional 307,500 ADSs at the public offering price, less underwriting discounts. The Offering is expected to close on or about November 27, 2024, subject to the satisfaction of customary closing conditions.

IPOs

WYHG

Reported Earlier, Wing Yip Food Prices Its $8.2M Initial Public Offering Of 2.05M American Depositary Shares At $4/ADS

Guidance
In the Group's Annual Report 2023, Cadeler provided guidance for the financial year ending 31 December 2024 indicating that full-year revenue was expected to fall within the range of EUR 225 million to EUR 245 million, while full-year EBITDA was expected to be between EUR 105 million and EUR 125 million. Cadeler has today increased its revenue guidance for the financial year 2024, as it now expects full-year revenue to fall within the range of EUR 243 million to EUR 253 million, principally due to clients calling more options under the Group's existing contracts than was previously assumed, higher vessel utilisation as a result of the Group having secured contracts for the provision of operations and maintenance services between installation projects, and the receipt of termination fees in respect of a vessel reservation agreement. In addition, Cadeler has revised and narrowed its EBITDA guidance within the upper end of the range it has previously communicated, as it now expects full-year EBITDA to range between EUR 115 million and 125 million.

Guidance

CDLR

Cadeler Expects FY24 Revenue Of €243M-€253M (Prior €225M-€245M)

If finalized, the loan would support the construction of Rivian's next facility in Stanton Springs North, near the city of Social Circle, Georgia, substantially expanding the company's domestic production capacity to support demand from the United States and international markets. This loan from DOE would provide significant funding for production of the company's midsize platform, which underpins the R2, a midsize SUV, and the R3/R3X, a midsize crossover. Designed, engineered, and built in America to deliver an incredible combination of capability, function, performance, and pricing, Rivian believes its R2 and R3 vehicle lines will be critical drivers in the company's long-term growth and profitability.

RIVN

Reported Earlier, Rivian Secures Conditional $6.6B DOE Loan Commitment To Expand Electric Vehicle Manufacturing And Development In US

Cadeler Reported Q3 Revenue Of €81M Vs €23M YoY

Financial analyst Jim Cramer&#8216;s recent recommendation to &#8220;own&#8221; Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) stocks has triggered a widespread investor revolt, with social media users loudly proclaiming their intent to do the opposite.
What Happened: CNBC&#8217;s &#8220;Mad Money&#8221; host Cramer&#8217;s Monday statement on X, &#8220;Apple, own it, don&#8217;t trade it!&#8221; quickly became a catalyst for what traders call the &#8216;Inverse Cramer&#8217; phenomenon—a strategy where investors systematically bet against his stock recommendations.
Online commentary ranged from satirical to scathing. One user, Tommy Famous, criticized Cramer as a &#8220;financial QVC&#8221; who has &#8220;led audiences into losses,&#8221; suggesting his recommendations are more entertainment than serious financial advice.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Jim Cramer, you've officially cemented yourself as the ultimate inverse indicator. Every word you utter is like a green light for the opposite trade. ‘Apple, own it, don't trade it'? Nah, that translates to SELL IT IMMEDIATELY and SHORT IT TO THE GROUND. You're not a market…
&mdash; Tommy Famous (@TommyBeFamous) <a href="https://twitter.com/TommyBeFamous/status/1861055066964123941?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/global/24/11/42179729/as-nvidia-maintains-chip-supremacy-jim-cramer-says-the-so-called-enemies-of-semiconductor-giant-arent-really-enemies">As Nvidia Maintains Chip Supremacy, Jim Cramer Says Foes Of Semiconductor Giant &#8216;Aren&#8217;t Really Enemies&#8217;</a>
Notable social media reactions included Thomas Peters <a href="https://x.com/thomasopeters/status/1861106660028358992">describing</a> it as &#8220;a great run&#8221; but ultimately follows the Inverse Cramer strategy. Another user <a href="https://x.com/Kyl0Z3n/status/1861062070470332662">humorously</a> suggested it&#8217;s time to sell Apple shares. Some users even pledged to <a href="https://x.com/thecryptomars/status/1861055235235422225">switch</a> technology brands in response. 
The phenomenon isn&#8217;t new. In October 2022, Tuttle Capital launched ETFs specifically designed to track and potentially profit from Cramer&#8217;s stock picks—including an &#8220;Inverse Cramer&#8221; fund that recently announced its shutdown.
Matthew Tuttle, CEO of Tuttle Capital, stated the ETF&#8217;s original mission was to &#8220;point out the danger of following TV stock pickers&#8221; and demonstrate the <a href="https://www.benzinga.com/etfs/specialty-etfs/24/01/36793492/exclusive-inverse-cramer-etf-shuts-down-how-the-magnificent-7-stocks-factor-in-and-a-broken-c">lack of consistent accountability</a> in financial media recommendations.
It is interesting to note that Cramer also predicted Vice President Kamala Harris's victory over now President-elect Donald Trump in the 2024 election on Nov. 4, <a href="https://www.cnbc.com/2024/11/04/cramer-says-mondays-action-suggests-some-anticipate-a-harris-win.html">according</a> to CNBC. "I'm not sure the market's right about what a Harris presidency would mean for business, but at least now we have a blueprint for what Wall Street thinks it'll mean," he said.
Price Action: Apple&#8217;s stock closed Monday at $232.87, up 1.31% for the day, with a year-to-date gain of 25.44%, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42180029/ark-invest-shakes-up-portfolio-with-big-tesla-and-amazon-trades">Cathie Wood-Led Ark Invest&#8217;s Latest Portfolio Maneuver: Dumps Tesla And Palantir Shares, Buys Amazon And AMD Stock</a></li>
</ul>
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Equities

AAPL

Jim Cramer's Apple Endorsement Sparks 'Inverse Cramer' Backlash As Social Media Users Mock His 'Own It' Advice

Reported Earlier, Replimune Prices $140M Upsized Public Offering Of&nbsp;6,923,000 Common Shares At $13/Share

REPL

Reported Earlier, Replimune Prices $140M Upsized Public Offering Of 6,923,000 Common Shares At $13/Share

SKYSCRAPER-01 is a global Phase III, randomized, double-blinded study evaluating tiragolumab plus Tecentriq compared to Tecentriq alone in 534 patients with PD-L1-high previously untreated, locally advanced unresectable or metastatic NSCLC. Patients were randomized 1:1 to receive either tiragolumab plus Tecentriq or placebo plus Tecentriq, until disease progression, loss of clinical benefit, or unacceptable toxicity. The study did not reach the primary endpoint of overall survival at the final analysis. The overall safety profile observed remained consistent with longer follow-up, and no new safety signals were identified. The detailed data will be presented at a medical meeting in 2025.

RHHBF

RHHBY

RHHVF

Roche's Genentech Provides Update On SKYSCRAPER-01 Phase III Study In PD-L1-High NSCLC Patients

Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value of up to $1.5 billion
Poseida to join the Roche Group and advance its innovative pipeline of non-viral, TSCM-rich CAR-T therapies and genetic medicines as part of Roche's Pharmaceuticals

Poseida Therapeutics To Be Acquired bB Roche In $1.5B Deal, Stockholders To Receive Up To $13/ Share In Cash

NASA has selected Elon Musk&#8216;s SpaceX to provide launch services for a rotorcraft lander mission aimed at exploring the largest moon of the planet Saturn in July 2028
What Happened: The deal is priced at about $256.6 million, including launch services and other related costs. 
The mission is expected to fly in the period from July 5 to July 25, 2028, on a SpaceX Falcon Heavy rocket from Florida to explore the moon called Titan. 
&#8220;Dragonfly centers on novel approach to planetary exploration, employing a rotorcraft-lander to travel between and sample diverse sites on Saturn's largest moon,&#8221; NASA said in a statement.
The mission is aimed at identifying the habitability of Titan's environment and searching for chemical indications of whether water-based or hydrocarbon-based life once existed on Saturn's moon, among other goals.
Why It Matters: SpaceX has multiple contracts with NASA to fly astronauts and cargo to the International Space Station (ISS) and also to <a href="https://www.benzinga.com/news/24/07/39870115/spacex-ceo-elon-musk-says-safe-destruction-of-international-space-station-will-be-a-very-dramatic-ev">bring down the space station</a> upon its retirement around 2030. 
NASA is also relying on a particular version of SpaceX&#8217;s Starship launch vehicle called the <a href="https://www.benzinga.com/24/11/42108681/spacex-shows-off-conceptual-version-of-starship-which-will-help-humans-land-back-on-moon-in-over-50-yrs">Human Landing System or HLS</a> to enable astronauts to land back on the surface of the Moon for the first time since 1972.
During the Artemis 3 mission, slated for no earlier than September 2026, the Starship HLS will be launched first and it will wait for NASA's Orion spacecraft in lunar orbit after filling its tanks in space. Once the Orion spacecraft arrives, the HLS will dock with it. Two of the four crew members on the mission will transfer from Orion to Starship and descend to the surface of the moon.
The last time humans set foot on the Moon was in 1972 <a href="https://www.benzinga.com/news/24/01/36692749/just-a-worse-version-of-apollo-elon-musk-baffled-by-nasa-veterans-push-to-ditch-spacex-blue-origin-a" target="_blank" rel="noreferrer noopener">with Apollo 17</a>. Since then, no crew has traveled beyond low-Earth orbit.
While SpaceX is not yet listed on the exchanges, investors can leverage Destiny Tech100 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NYSE">DXYZ</a>) and Cathie Wood&#8216;s Ark Venture Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKVX#NASDAQ">ARKVX</a>) to participate in the Musk-led space company's growth.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42058338/byd-makes-a-million-nevs-in-less-than-2-months" target="_blank" rel="noreferrer noopener">BYD Makes A Million NEVs In Less Than 2 Months After Beating Tesla For The First Time Since 2022 In Quarterly Revenue</a></li>
</ul>
Photo courtesy: NASA

SPACE

ARKVX

DXYZ

SpaceX Falcon Heavy To Launch NASA's Dragonfly Mission To Saturn's Largest Moon In 2028

The Company intends to use the net proceeds of this offering, together with cash on hand, including from recent sales under the Company's "at the market" offering program, to repay the $478.0 million mortgage loan with a fixed effective interest rate of approximately 9.0% and which is secured by its Washington Square property. Pending such use, the Compa

Macerich Prices Upsized $395M Public Offering Of 20M Common Shares At $19.75/Share

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Focus Universal (NASDAQ:<a href="https://investorplace.com/stock-quotes/fcuv-stock-quote/">FCUV</a>) just reported results for the fourth quarter of 2023.<ul><li>Focus Universal reported earnings per share of -3 cents.</li><li>The company reported revenue of $282,342.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/fcuv-stock-earnings-focus-universal-for-q4-of-2023/">FCUV Stock Earnings: Focus Universal Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FCUV Stock Earnings: Focus Universal Reported Results for Q4 2023

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we get into all of the hottest news happening on Tuesday morning!



Moving stocks this morning are earnings reports, clinical trial data and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) stock is rocketing close to 50% after <a href="https://www.nasdaq.com/press-release/biophytis-announces-its-2023-financial-results-and-provides-an-update-on-its-business">announcing its 2023 results</a>.</li>



<li>MyMD Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mymd-stock-quote/">MYMD</a>) shares are rising over 26% after revealing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318224188&amp;type=PDF&amp;symbol=MYMD&amp;cdn=8720a94b32a7a67a8aeafa7ccea08ffe&amp;companyName=MyMD+Pharmaceuticals+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-08">securities purchase agreement</a>.</li>



<li>Acorda Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/acor-stock-quote/">ACOR</a>) stock is soaring more than 26% <a href="https://www.nasdaq.com/press-release/acorda-therapeutics-announces-nasdaq-delisting-notification-2024-04-03">ahead of its delisting</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) shares are surging over 26% without any clear news this morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is gaining nearly 17% despite a lack of news today.</li>



<li>Anghami (NASDAQ:<a href="https://investorplace.com/stock-quotes/angh-stock-quote/">ANGH</a>) shares are increasing more than 16% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318224555&amp;type=PDF&amp;symbol=ANGH&amp;cdn=55a7014ffb2fa2fae4e6fc7d8965ee6d&amp;companyName=Anghami+Inc.&amp;formType=SC+13D&amp;formDescription=General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-04-08">following an investor update</a>.</li>



<li>MediaCo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdia-stock-quote/">MDIA</a>) stock is climbing over 14% on Tuesday morning.</li>



<li>Brainstorm Cell (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcli-stock-quote/">BCLI</a>) shares are getting a more than 13% boost with an update on its <a href="https://www.nasdaq.com/press-release/brainstorm-cell-therapeutics-announces-agreement-with-fda-on-a-special-protocol">Phase 3 clinical trial</a>.</li>



<li>Destiny Tech100 (NYSE:<a href="https://investorplace.com/stock-quotes/dxyz-stock-quote/">DXYZ</a>) stock is jumping over 13% as it <a href="https://seekingalpha.com/article/4682523-destiny-tech100-inc-dxyz-rose-800-percent-in-just-days-a-closer-look">continues a recent rally</a>.</li>



<li>RenovoRx (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnxt-stock-quote/">RNXT</a>) shares are up more than 12% on <a href="https://www.nasdaq.com/press-release/renovorx-announces-%2411.1-million-at-market-private-placement-2024-04-08">an offer to take it private</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Vincerx Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/vinc-stock-quote/">VINC</a>) stock is crashing over 53% on <a href="https://www.nasdaq.com/press-release/vincerx-pharma-presents-positive-preliminary-phase-1-data-for-vip236-and-updates-on">preliminary Phase 1 clinical trial data</a>.</li>



<li>Focus Universal (NASDAQ:<a href="https://investorplace.com/stock-quotes/fcuv-stock-quote/">FCUV</a>) shares are plummeting more than 30% on Tuesday morning.</li>



<li>UTime (NASDAQ:<a href="https://investorplace.com/stock-quotes/wto-stock-quote/">WTO</a>) stock is diving over 23% after a major rally yesterday.</li>



<li>Vivos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vvos-stock-quote/">VVOS</a>) shares are tumbling more than 22% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318224743&amp;type=PDF&amp;symbol=VVOS&amp;cdn=01c96e38759646a4b342ce7c55cb1bd1&amp;companyName=Vivos+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-09">proposed public offering</a>.</li>



<li>BioSig Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/bsgm-stock-quote/">BSGM</a>) stock is taking an over 21% beating on Tuesday.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) shares are decreasing more than 15% on <a href="https://seekingalpha.com/article/4682824-maxeon-solar-technologies-preliminary-q4-earnings-dont-buy-this-dip?source=content_type%3Areact%7Csection_asset%3Arelated-analysis%7Csection%3Aright_rail%7Cfirst_level_url%3Aarticle%7Cline%3A1%7Cpos%3Aundefined">preliminary earnings results</a>.</li>



<li>Eco Wave Power Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/wave-stock-quote/">WAVE</a>) stock is dropping over 14% after a <a href="https://investorplace.com/2024/04/why-is-eco-wave-power-wave-stock-up-115-today/">massive rally yesterday</a>.</li>



<li>Guardion Health Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/">GHSI</a>) shares are sliding more than 12% on plans for a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318223987&amp;type=PDF&amp;symbol=GHSI&amp;cdn=81af5524a2ccf8e9d81bd1343671bec4&amp;companyName=Guardion+Health+Sciences+Inc.&amp;formType=DEFM14A&amp;formDescription=Definitive+proxy+statement+relating+to+merger+or+acquisition&amp;dateFiled=2024-04-08">special shareholder meeting</a>.</li>



<li>DigiAsia (NASDAQ:<a href="https://investorplace.com/stock-quotes/faas-stock-quote/">FAAS</a>) stock is declining almost 12% after a rally yesterday.</li>



<li>Erayak Power Solution (NASDAQ:<a href="https://investorplace.com/stock-quotes/raya-stock-quote/">RAYA</a>) shares close out our pre-market stock movers down over 11%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-april-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

An announcement from Focus Universal Inc (FCUV) is now available. Focus Universal Inc. has appointed Warren Wang as its new Vice President and Chie...

Focus Universal Welcomes New VP and Strategy Chief

The latest update is out from Focus Universal Inc (FCUV). Focus Universal Inc. is set to captivate potential clients and partners with a presentati...

Focus Universal Inc. Outlines Future and Plans Subsidiary Spin-Off

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Focus Universal (NASDAQ:<a href="https://investorplace.com/stock-quotes/fcuv-stock-quote/">FCUV</a>) just reported results for the first quarter of 2024.<ul><li>Focus Universal reported earnings per share of -2 cents.</li><li>The company reported revenue of $219,158.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/fcuv-stock-earnings-focus-universal-for-q1-of-2024/">FCUV Stock Earnings: Focus Universal Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FCUV Stock Earnings: Focus Universal Reported Results for Q1 2024

The latest update is out from Focus Universal (FCUV). Warren Wang stepped down as Vice President and Chief Strategy Officer of Focus Universal Inc....

Focus Universal Announces Vice President's Resignation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Focus Universal (NASDAQ:<a href="https://investorplace.com/stock-quotes/fcuv-stock-quote/">FCUV</a>) just reported results for the second quarter of 2024.<ul><li>Focus Universal reported earnings per share of -2 cents.</li><li>The company reported revenue of $19,753.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/fcuv-stock-earnings-focus-universal-for-q2-of-2024/">FCUV Stock Earnings: Focus Universal Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FCUV Stock Earnings: Focus Universal Reported Results for Q2 2024

Brenmiller Energy Ltd., Agape ATP, and Focus Universal are the 3 Penny Stocks to watch on September 3, 2024, based on&nbsp;TipRanks' Penny Stock Sc...

3 Penny Stocks to Watch Now, 9/03/24

Focus Universal gets approval to shift listing to Nasdaq Capital Market

An update from Focus Universal ( ($FCUV) ) is now available. Focus Universal Inc., a tech company specializing in IoT and 5G, has announced its app...

Focus Universal Transfers Markets Amid Growth and Compliance Efforts

ACOR

ADXN

ANGH

ATPC

BCLI

BNRG

BPTS

BSGM

FAAS

FCUV

GHSI

MAXN

MDIA

MYMD

RAYA

RNXT

VINC

VVOS

WAVE

Press Releases

Focus Universal Inc. Engages PX SPAC Capital Inc.

Management

Focus Universal Inc. Announces  Warren Wang as Chief Strategy Officer

Focus Universal Inc. Announces  Board Approval for Spin-Off of Lusher Inc.

Events

Focus Universal Inc. to Attend the IoT Tech Expo North America 2024

Focus Universal Announces SEC Financial Reporting Software Achieves Thousand Times Faster Than Traditional Manual Approach and Launches Nationwide Non-Deal Roadshow

Comments

Focus Universal

Focus Universal (FCUV) Opciones

Focus Universal (NASDAQ:FCUV) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL